Neurofibromatosis 1: a literature review
Keywords:
neurofibromatosis-1, NF-1, neurofibromatosis type 1, peripheral neurofibromatosis, classic neurofibromatosis, von Recklinghausen neurofibromatosis, von Recklinghausen diseaseAbstract
The article presents modern data on a problem of neurofibromatosis as one of the most widespread hereditary disease. The history of studying of this disease is given. Several classifications, epidemiology, and genetics are given in the paper. The author analyzes the variety of clinical signs of NF1 and its diagnostic criteria in details. Taking into consideration the variety of lesions at NF1 the required methods and number of examinations are discussed. Paper provides possible approaches to the treatment of NF1 including surgical.References
Бочков Н. П., Мордовцев В. Н., Яхно Н. Н. и др. Нейрофиброматоз: состояние проблемы, нерешенные вопросы и пути изучения //Вестн. дерматол.—1994.—№4.—С.14—18.
Массон П. Опухоли человека. Гистологическая диагностика // Пер. с фр..—M.: Медицина, 1965. — 514с.
Мордовцев В.Н., Мордовцева В.В., Филиппова М.Г. и др. Ранняя диагностика нейрофиброматоза 1-го типа—основа профилактики осложнений системной патологии //Рус. мед. журн.—1997.—№11,T.V.—С.1—10.
Патоморфология нервной системы //Под ред. И.Т. Никулеску/Пер. с румын.—Бухарест: Мед.издат,1963. —995с.
Савицкий В.А., Черепанов А.Н. Нейрофиброматоз Реклингаузена.—М.: Медицина, 1972. —249c.
Умаханов Р.У. Периферическая нейрофиброма //Хирургия.—1986.—№8.—С.147.
Akenside M. Observations on cancers //Med. Trans. Coll. Phys. Lond.—1785.—N.1.—P.64—92.
Ars E., Serra E., Garcia J. et al. Estivill. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 //Hum. Mol. Genet.—2000.—V.9, N.2.—P.237—244.
Balcer L.J., Liu G.T., Heller G., Bilaniuk L. et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging //Am. J. Ophthalmol.—2001.—V.131, N.4.—P.440—445.
Barker D., Wright E., Nguyen K. et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17 //Science—1987.—V.236.—P.1098—1102.
Baskin K.M., Chang J. Peripheral Neurofibromatosis //Departament of Radiology University of Iowa College of Medicine. Virtual Hospital.—1995.—N4.
Benchekroun O., Lamari H., Moutawakkil A., Laouissi N. et al. Ophthalmological manifestations of von Recklinghausen disease //J. Fr. Ophtalmol.—1997—V.20,N10.—P.753—757.
Bernards A. Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs //Biochim. Biophys. Acta.—1995.—V.1242.—P.43—59.
Bilaniuk L.T., Molloy P.T., Zimmerman R.A., Phillips P.C. et al. Neurofibromatosis type 1: brain stem tumours //Neuroradiol.—1997.—V.39,N.9.—P.642—653.
Bononi M., De Cesare A., Stella M.C., Fiori E. et al. Galati G., Atella F., Angelini M., Cimitan A., Lemos A., Cangemi. Isolated intestinal neurofibromatosis of colon. Single case report and review of the literature //Dig. Liver Dis.—2000.—V.32,N.8.—P.737—744.
Borberg A. Clinical and genetic investigations into tuberous sclerosis and Recklinghausen’s neurofibromatosis. Contributions to elucidation of interrelationship and eugenics of the syndromes //Acta Psychiatr. Neurol. Scand.—1951.— V.71 suppl.—P.1—239.
Buske A., Gewies A., Lehmann R., Ruther K. et al. Tinschert. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1) //Am. J. Med. Genet.—1999.—V.86,N4.—P.328—333.
Carey JC, Baty BJ, Johnson JP. Morrison T. et al. The genetic aspects of neurofibromatosis //Annals New York Acad. Sci.—1986.—V.486.—P.45—46.
Cawthon R.W., Weiss M., Xu G. et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations //Cell.—1990.—V.62.—P.193—201.
Chapman P.H., Curtin H.D., Cunningham M.J. An unusual pterygopalatine meningocele associated with neurofibromatosis type 1. Case report //J. Neurosurg.—2000.—V.93, N.3.—P.480—483.
Chateil J.F., Soussotte C., Pedespan J.M., Brun M. et al. MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis //Br. J. Radiol.—2001.—V.74(877),N.1.—P.24-31.
Clementi M., Battistella P.A., Rizzi L. et al. Headache in patients with neurofibromatosis type 1 //Headache.—1996.—V.36,N.1.—P.10.
Clementi M., Milani S., Mammi I., Boni S. et al. Neurofibromatosis type 1 growth charts //Am. J. Med. Genet.—1999.—V.87,N.4.—P.317—323.
Cormier J.M., Cormier F., Mayade F., Fichelle J.M. Arterial complications of neurofibromatosis //J. Mal. Vasc.—1999.—V.24,N.4.—P.281—286.
Crawford A.H., Schorry E.K. Neurofibromatosis in children: the role of the orthopaedist. J. Am. Acad. Orthop. Surg.—1999.—V.7,N.4.—P.217—230.
Crowe F.W. Axillary freckling as a diagnostic aid in neurofibromatosis //Ann. Intern. Med.—1964.—V.61.—P.1142—1143.
Crowe F.W., Schull W.J., Neel J.V. A clinical, pathological and genetic study of multiple neurofibromatosis.—Springfield IL, Charles C Thomas, 1956.
Cutler S.J., Young Jr J.L. Third National Cancer Survey: Incidence data //Natl. Cancer Inst Monogr.—1975.—V.41.—P.1—454.
De Clue J.E., Cohen B.D. Lowy D.R. Identification and characterization of the neurofibromatosis 1 protein product // Proc. Nat. Acad. Sci.—1991.—V.88.—P.9914—9918.
De Bella K., Poskitt K., Szudek J., Friedman J.M. Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis1 inchildren //Neurol.—2000.—V.54,N.8.—P.1646—1651.
De Bella K., Szudek J., Friedman J.M. Use of the national institutes of health criteria for diagnosis of neurofibromatosis1 inchildren //Pediatrics.—2000.—V.105(Pt1)—P.608—614.
Deliganis A.V., Geyer J.R., Berger M.S. Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma //Neurosurg.—1996.—V.38,N.6.—P.1114—1119.
Di Mario F.J. Jr., Langshur S. Headaches in patients with neurofibromatosis 1 //J. Child. Neurol.—2000.—V.15,N.4.—P.235—238.
Duffner P.K., Cohen M.E. Isolated optic nerve gliomas in children with and without neurofibromatosis //Neurofibromatosis.—1988.—N.1.—P.201—211.
Dugoff L., Sujansky E. Neurofibromatosis type 1 and pregnancy //Am. J. Med. Genet.—1996.— V.61,N.1.—P.7—10.
Durrani A.A., Crawford A.H., Chouhdry S.N. et al. Modulation of spinal deformities in patients with neurofibromatosis type 1 //Spine.—2000.—V.25,N.1.—P.69—75.
Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma //Advan. Neurol.—1981.—V.29.—P.57—65.
Es S.V., North K.N., McHugh K., Silva M.D. MRI findings in children with neurofibromatosis type 1: a prospective study //Pediatr. Radiol.—1996.—V.26—P.478—487.
Ferner R.E., Lucas J.D., O’Doherty M.J., Hughes R.A. et al. Evaluation of (18) fluorodeoxyglucose positron emission tomography ((18) FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 //J. Neurol. Neurosurg. Psychiatry.—2000.—V.68,N.3.—P.353—357.
Ferrozzi F., Zuccoli G., Bacchini E., Piazza P. et al. Extracerebral neoplastic manifestations in neurofibromatosis 1: integrated diagnostic imaging //Radiol. Med.—1998.—V.96,N.6.—P.562—569.
Fink D., Schneider C., Wight E. et al. Neurofibromatosis of the breast in a patient with Morbus von Recklinghausen //Gunakol. Geburtshilfliche Rundsch.—2000.—V.40,N.1.—P.47—49.
Fossali E., Signorini E., Intermite R.C., Casalini E. et al. Renovascular disease and hypertension in children with neurofibromatosis //Pediatr. Nephrol.—2000.—V.14, N.8—9.—P.806—810.
Friedman J.M. Epidemiology of neurofibromatosis type 1 //Am. J. Med. Genet.—1999.—V.89,N.1.—P.1—6.
Friedman J.M. Neurofibromatosis 1. Funded by the NIH. Developed at the University of Washington, Seattle, 5 September, 1998.
Gallino G., Belli F., Tragni G. et al. Association between cutaneus melanoma and neurofibromatosis type 1: analysis of three clinical cases and review of the literature //Tumori.—2000.—V.86, N.1.—P.70—74.
Gocer A.I., Tuna M., Gezercan Y., Boyar B., Bogdatoglu. Multiple anterolateral cervical meningoceles associated with neurofibromatosis //Neurosurg. Rev.—1999.—V.22,N.2—3.—P.124.
Griffiths P.D., Blaser S., Mukonoweshuro W., Armstrong D. et al. Neurofibromatosis bright objects in children with neurofibromatosis type 1: proliferative potential? //Pediatrics—1999.—V.104, N.4.—P.49.
Gupta A., Cohen B.H., Ruggieri P. et al. A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1) //Neurol.—2000.—V.54 suppl.3.—P.12—13.
Gutmann D.H. Recent insights into neurofibromatosis type 1: clear genetic progress //Arch. Neurol.—1998.—V.55.—P.778—800.
Gutmann D.H., Collins F.S. The neurofibromatosis type 1 gene and its protein product, neurofibromin //Neuron—1993.—V.10.—P.335—343.
Gutmann D.H., Wood D.L., Collins F.S. Identification of the neurofibromatosis type 1 gene product //Proc. Nat. Acad. Sci.—1991.—V.88.—P.9658—9662.
Gutmann D.H., Aylsworth A., Carey J.C. et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 //JAMA—1997.—V.278,N.1.—P.51—57.
Hamilton S.J., Allard M.F., Friedman J.M. Cardiac findings in an individual with neurofibromatosis 1 and sudden death //Am. J. Med. Genet.—2001.—V.100, N.2.— P.95—99.
Hofman K.J., Harris E.L., Bryan N, Denckla M. Neurofibromatosis type 1: the cognitive phenotype //J. Pediatr.—1994.—V.124.—P.1—8.
Howell S.J., Wilton P., Lindberg A., Shalet S.M. Growth hormone and neurofibromatosis //Horm. Res.—2000.—V.53, suppl, 1.—P.70—76.
Huson S.M., Harper P.S., Compston A.S. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales //Brain—1988.—V.111,N.6.—P.1355—1381.
Huson S.M., Hughe 1 RAC. The Neurofibromatoses: a pathogenetic and clinical overview.—London: Chapman & Hall, 1994.
Huson S.M., Thrush D.C. Central neurofibromatosis //Quartely Journal of Medicine—1985.—V.55.—P.213—224.
Joy P., Roberts C., North K., de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1 //Dev. Med. Child. Neurol.—1995.—V.37,N.10.—P. 906—914.
Jyzwiak S., Kasprzyk Obara J., Domanska Pakie D. Phacomatoses: structural substare of epilepsy //Neurol. Neurochir. Pol.—2000.—V.33, suppl, 1.— P.243—251.
Karnes P.S. Neurofibromatosis: a common neurocutaneous disorder //Mayo Clin. Proc.—1998.—V.73,N.11.— P.1071—1076.
Keutel C., Vees B., Krimmel M. et al. Oral, facial and cranial manifestations of von Recklinghausen neurofibromatosis (NF) //Mund Kiefer Gesichtschir.—1997.—V.1,N.5.—P.268—271.
King A.A., Debaun M.R., Riccardi V.M., Gutmann D.H. Malignant peripheral nerve sheath tumors in neurofibromatosis 1 //Am. J. Med. Genet.—2000.—V.93, N.5.—P.388—392.
Klecamp J., Samii M. Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis //Neurosurgery.—1998.—V.42, N.2.—P.279—289.
Korf B.R. Malignancy in neurofibromatosis type 1 //Oncologist—2000.—V.5,N.6.—P.477—485.
Kurimoto M., Hirashima Y., Hayashi N., Endo S. et al. Suboccipital meningocele presenting as a huge retropharyngeal mass in a patient with neurofibromatosis type 1. Case report //J. Neurosurg.—1999.—V.91,N.3.—P.503—505.
Lau N., Feldkamp M.M., Roncari L. et al. Loss of neurofibromin is associated with activation of RAS/MAPK and P13-K/AKT signaling in a neurofibromatosis 1 astrocytoma //J. Neuropathol. Exp. Neurol.—2000.—V.59, N.9.—P.750—767.
Lever W.F., Schaumburg-Lever G. Hystopathology of the skin.—Philadelphia, 1983.
Lewis R.A., Gerson L.P., Axelson K.A. et al. Von Recklighausen neurofibromatosis I. Incidence of optic gliomas //Ophthalmol.—1984.—V.91.—P.929—935.
Lewis R.A., Riccardi V.M. Von Recklinghausen neurofibromatosis: incidence of iris hamartomas //Ophthalmol.—1981.—V.88.—P.348—354.
Lin A.E., Birch P.H., Korf B.R .et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1 //Am. J. Med. Genet.—2000.—V.95,N.2.—P.108—111.
Lisch K. Ueber Beterlingung der Augen, Insbesondere das Vorkommen von Irisnotchen bei der Neurofibromatose (Recklinghausen) //Zeitschriff fыr Augenheilkende.—1937.—V.93.—P.137—143.
Listernick R. Darling C., Greenwald M. et al. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history //J. Pediatr.—1995.—V.127.—P.718—722.
Listernick R., Charrow J., Greenwald M. et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study //J. Pediatr.—1994.—V.125.—P.63—66.
Listernick R., Charrow J., Gutmann D.H. Intracranial gliomas in neurofibromatosis type 1 //Am. J. Med. Genet.—1999.—V.89,N.1.—P.38—44.
Listernick R., Charrow J., Tomita T., Goldman S. Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type 1 //J. Neurooncol.—1999.—V.45,N.2.—P.185—190.
Matsui I., Tanimura M., Kobayashi N. et al. Neurofibromatosis type 1 and childhood cancer //Cancer—1993.—V.72,N.9.—P.2746—2754.
Mc Gaughran J.M., Harris D.I., Donnai D. et al.. A clinical study of the neurofibromatosis type1 innorth west England //J. Med. Genet.—1999.—V.36,N3.—P.197—203.
Miller M., Hall J.G. Possible maternal effect on severity of neurofibromatosis //Lancet.—1978.—V.2.—P.1071-1073.
Miller R.M., Sparkes R.S. Segmental neurofibromatosis //Archives of Dermatology—1977.—V.113.—P.837—838.
Moore B.D., Slopis J.M., Schomer D. et al. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis //Neurol.—1996.—V.46.—P.1660—1668.
Nielsen G.P., Stemmer-Rachamimov A.O., Ino Y. et al. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation //Am. J. Pathol.—1999.—V.155,N.6.—P.1879—1884.
Nordback P., Halkic N., Boumghar M. Intrathoracic tumors in von Recklinghausens neurofibromatosis //Schweiz Med. Wochenschz.—2000.—V.130,N.31—32.—P.1105—1111.
North K.N. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. //J. Child. Neurol.—1993.—V.8.—P.395—402.
North K.N.. Riccardi V., Samango-Sprouse C. et al. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force //Neurol.—1997.—V.48.—P.1121—1127.
Ogose A., Hotta T., Morita T. et al. Multiple schwannomas in the peripheral nerves //J. Bone Joint Surg. Br.—1998.—V.80,N.4.—P.657—661.
Packer R.J., Lange B. Ater J. et al. Carboplatinum and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood //J. Clin. Oncol.—1993.—V.11.—P.850—856.
Parazzini C. Triulzi F., Bianchini E. et al. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation //AJNR Am. J. Neuroradiol.—1995.—V.16.—P.1711—1718.
Parisini P., Di Silvestre M., Greggi T. et al. Surgical correction of dystrophic spinal curves in neurofibromatosis. A review of 56 patients //Spine.—1999.—V.24,N.21.—P.2247—2255.
Park K.C., Choi H.O., Han W.S. et al. Identification of two novel frame shift mutations of the NF1 gene in Korean patients with neurofibromatosis type 1 //J. Korean Med. Sei.—2000.—V.15, N.5.—P.542—544.
Plaat B.E., Molenaar W.M., Mastik M.F., Hoekstra H.J. et al. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheat tumors: sporadic vs neurofibromatosis type 1 associated malignant schwannomas //Int. J. Cancer.—1999.—V.83,N.2.—P.171—177.
Pollack I.F., Shultz B., Mulvihill J.J. The management of brainstem gliomas in patients with neurofibromatosis 1 //Neurol.—1996.—V.46,N.6.—P.1652—1660.
Preiser S.A., Davenport C.B. Multiple neurofibromatosis (von Recklinghausen’s disease).Clinical manifestations and its inheritance; with description of a case //Am. J. Med. Sci.—1918.—V.156.—P.507—540.
Quarles Van Ufford Mannesse P., Castro Cabezas M., Vroom T.M. et al. A patient with neurofibromatosis type 1 and phaeochromocytoma //J. Intern. Med.—1999.—V.246,N.2.—P.231—234.
Rapado F., Simo R., Small M. Neurofibromatosis type 1 of the head and neck: dilemmas in management //J. Laryngol. Otol.—2001.—V.115, N.2.—P.151—154.
Rasmussen S.A., Friedman J.M. NF1 gene and neurofibromatosis 1 //Am. J. Epidemiol.—2000.—V.151,N.1.—P.33—40.
Rasmussen S.A., Yang Q., Friedman J.M. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates //Am. J. Hum. Genet.—2001.—V.68,N.5.—P.1110—1118.
Reed R.J. Cutaneous manifestations of neural crest disorders (neurochristopathies) (Review) //Int. J. Dermatol.—1977.—V.16.—P.807—826.
Riccardi V.M. Neurofibromatsis: clinical heterogeneity //Curr. Probl. Cancer—1982.—V.7.—P.1—34.
Riccardi V.M., Eichner J.E. Neurofibromatosis: phenotype, natural history and pathogenesis. 2nd edition.—Baltimore, Md: Johns Hopkins University Press, 1992.
Rosenbaum T., Engelbrecht V., Krцlls W. et al. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice //Brain. Dev.—1999.—V.21,N.4.—P.268—273.
Rouleau G.A., Merel P., Lutchman M. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2 //Nature.—1993.—V.363.—P.515—521.
Rubenstein A.E., Korf B.R. Neurofibromatosis. A handbook for patients, families and health-care professionals.—Georg Thieme Verlag, Stuttgart. New York.—1990.
Rutkowski J.L., Wu K., Gutmann D.H. et al. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1 //Hum. Mol. Genet.—2000.—V.9,N7.—P.1059—1066.
Samuelsson B. Neurofibromatosis (von Recklinghausen’s disease): a clinical, psychiatric and genetic study.—MD Thesis,University of Gцteborg,Sweden, 1981.
Schwarz J., Belzberg A.J. Malignant peripheral nerve sheath tumors in the setting of segmental neurofibromatosis. Case report //J. Neurosurg.—2000.—V.92,N.2.—P.342—346.
Seizinger R.R., Rouleau G.A., Ozelius L.J. et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene //Cell.—1987.—V.49.—P.589-594.
Sergeyev A.S. On the mutation rate of neurofibromatosis //Humangenet.—1975.—V.28.—P.129—138.
Shen M.H., Harper P.S., Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1) //J. Med. Genet.—1996.—V.33.—P.2—17.
Shuper A., Horev G., Kornreich L. et al. Visual pathway glioma: an erratic tumour with therapeutic dilemmas //Arch. Dis. Child.—1997.—V.76,N.3.—P.259—263.
Sorensen S.A., Mulvihill J.J., Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis //N. Engl. J. Med.—1986.—V.314.—P.1010—1014.
Stout A.P. Tumors of the peripheral nervous system //AFIP Atl. Tum. Pathol.—1949.—V.6.—P.1—57.
Stumpf D.A., Alksne J.F., Annegers J.F. et al. Neurofibromatosis //Arch. Neurol.—1988.—V.45.—P.575—578.
Szudek J., Birch P., Friedman J.M. Growth in North American white children with neurofibromatosis 1 (NF1) //J. Med. Genet.—2000.—V.37,N.12.—P.933—938.
Taylor M.A., Loughrey M.B., Toner P.G., Regan M.C. An unusual cause of biliary stricture in a patient with neurofibromatosis type 1 //Eur. J. Gastroenterol. Hepatol.—2001.—V.13, N2.—P.199—201.
Thakkar S.D., Feigen U., Mautner V. Spinal tumours in neurofibromatosis type 1: an MRI study of frequency multiplicity and variety //Neuroradiol.—1999.—V.41,N.9.—P.625—631.
Thomson A. On neuroma and neurofibromatosis.—Edinburgh, Turnbull & Spears, 1900.
Trofatter J.A., Mac Collin M.M., Rutter J.L. et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor //Cell.—1993.—V.72.—P.1—20.
Truhan A.P., Filipek P.A. Magnetic resonance imaging. Its role in the neuroradiologic evaluation of neurofibromatosis, tuberous sclerosis, and Sturge-Weber Syndrome //Arch. Dermatol.—1993.—V.129.—P.219—226.
Virdis R., Sigorini M., Laiolo A. et al. Neurofibromatosis type 1 and precocious puberty // J. Pediatr. Endocrinol. Metab.—2000.—V.13, suppl, 1.—P.841—844.
Viskochil D., Buchberg A.M., Xu G. et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus //Cell.—1990.—V.62.—P.187—192.
Viskochil D., White R., Cawthon R. The neurofibromatosis type 1 gene //Ann. Rev. Neurosci.—1993.—V.16.—P.183—205.
von Deimling A., Krone W., Menon A.G. Neurofibromatosis type 1: pathology, clinical features and molecular genetics //Brain Pathol.—1995.—V.5,N.2.—P.153—162.
von Recklinghausen F.D. Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen.— Berlin, Hirschwald, 1882.
von Tilesius W.G. Historia Pathologica Singularis Cutis Turpitudinis//J. Godofredi Rheinhardi Viri 50 Annorum. Leipzig, S.L. Crusius, 1793.
Waggoner D.J., Towbin J., Gottesman G., Gutmann D.H. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1 //Am. J. Med. Genet.—2000.—V.92,N.2.—P.132—135.
Wallace M.R., Marchuk D.A., Andersen L.B. et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients //Science.—1990.—V.249.—P.181—186.
Wang P.Y., Koufmann W.E., Koth C.W. et al. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging //Ann. Neurol.—2000.—V.47,N.4.—P.477—484.
Wolkenstein P. Decq P Neurofibromatosis //Neurochirurgic—1998.—V.44,N.4.—P.267—272.
Wolkenstein P., Durand-Zaleski I., Moreno J.C. et al. Cost evaluation of the medical management of neurofibromatosis 1: a prospective study in 201 patients //Br. J. Dermatol.—2000.—V.142.N.6.—P.1166—1170.
Wolkenstein P., Fruche B., Zeller J., Revuz J. Usefulness of screening investigations in neurofibromatosis type1. Astudy of 152 patients [see comments] //Arch. Dermatol.—1996.—V.132,N11.—P.1333—1336.
Woodruff J.M., Marshall M.L., Godwin T.A. et al. Plexiform (multinodular) schwannoma: a tumor simulating the plexiform neurofibroma //Am. J. Surg. Pathol.—1983.—V7.—P.691—697.
Young L.P., Stanley A., Menzoian J.O. An anterior tibial artery aneurysm in a patient with neurofibromatosis //J. Vasc. Surg.—2001.—V.33, N.5.—P.1114—1117.
Zhao J.Z., Han X.D. Cerebral aneurysm associated with von Recklinghausen’s neurofibromatosis: a case report //Surg Neurol.—1998.—V.50,N.6.—P.592—596.
Zoller M., Rembeck B., Akesson H.O., Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type1. Atwelve-year follow-up of an epidemiological study in Goterborg Sweden //Acta Derm. Venereol.—1995.—V.75,N.2.—P.136—140.
Zvulunov A., Barak Y., Metzeker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis [see comments] //Arch. Dermatol.—1995.—V.131,N.8.—P.904—908.
Zvulunov A., Weitz R., Metzker A. Neurofibromatosis type1 inchildhood: evaluation of clinical and epidemiologic features as predictive factors for severity //Clin. Pediatr. (Phila)—1998.—V.37,N.5.—P.295—299.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2001 Mykola Kvasnitskyi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
